Combating antibiotic resistance: a public health issue


Public awareness of the issue may be low, but antibiotic resistance is nevertheless a major threat to public health. The World Antibiotic Awareness Week that started on Monday November 16 is an opportunity to catch up with its current status thanks to a special report published by, which examines the challenges involved and the measures in place to avoid the problem.

Antibiotic resistance is the result of massive and sometimes inappropriate use of antibiotics, which can cause some bacteria to mutate and become resistant to existing treatments. The absence of medication effective against multi-resistant bacteria would open up the possibility of breaching our defenses against the progress of infectious diseases that we believe to be virtually eradicated, such as tuberculosis and plague.




Although these situations are still rare, the problem is growing and could result in the deaths of more than 10 million people worldwide by 2050. But antibiotic resistance is not a fatality: a rapid response by international bodies and appropriate use of antibiotics could stop the threat in its tracks.

In order to protect the “antibiotic capital” of entire populations, Sanofi is working alongside the French Ministry of Health to combat this threat on four main fronts: research into new and effective treatments for multi-resistant infections, the introduction of epidemiological monitoring networks to track the trend in bacterial responses to antibiotics, the definition of appropriate use for these drugs, and a campaign to raise the awareness of healthcare professionals and the public to the need for responsible use of antibiotics.


read the article on Responsible Antibiotherapy by Sanofi (in french)

Choose the topics that interest you, like: